Group One Trading’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-25,332
| Closed | -$478K | – | 2543 |
|
|
2019
Q3 | $478K | Buy |
25,332
+24,160
| +2,061% | +$456K | ﹤0.01% | 393 |
|
|
2019
Q2 | $14K | Buy |
1,172
+500
| +74% | +$5.97K | ﹤0.01% | 995 |
|
|
2019
Q1 | $9K | Sell |
672
-4,283
| -86% | -$57.4K | ﹤0.01% | 1020 |
|
|
2018
Q4 | $51K | Sell |
4,955
-1,200
| -19% | -$12.4K | ﹤0.01% | 888 |
|
|
2018
Q3 | $102K | Buy |
6,155
+847
| +16% | +$14K | ﹤0.01% | 820 |
|
|
2018
Q2 | $84K | Sell |
5,308
-3,537
| -40% | -$56K | ﹤0.01% | 841 |
|
|
2018
Q1 | $112K | Buy |
8,845
+1,568
| +22% | +$19.9K | ﹤0.01% | 726 |
|
|
2017
Q4 | $83K | Sell |
7,277
-20,020
| -73% | -$228K | ﹤0.01% | 840 |
|
|
2017
Q3 | $334K | Buy |
27,297
+2,404
| +10% | +$29.4K | ﹤0.01% | 515 |
|
|
2017
Q2 | $285K | Buy |
+24,893
| New | +$285K | ﹤0.01% | 540 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2078 |
|
|
2016
Q4 | – | Sell |
-853
| Closed | -$28K | – | 2065 |
|
|
2016
Q3 | $28K | Sell |
853
-5,253
| -86% | -$172K | ﹤0.01% | 865 |
|
|
2016
Q2 | $152K | Sell |
6,106
-177
| -3% | -$4.41K | ﹤0.01% | 528 |
|
|
2016
Q1 | $154K | Sell |
6,283
-1,797
| -22% | -$44K | ﹤0.01% | 503 |
|
|
2015
Q4 | $267K | Sell |
8,080
-17,085
| -68% | -$565K | ﹤0.01% | 504 |
|
|
2015
Q3 | $824K | Buy |
25,165
+15,706
| +166% | +$514K | 0.01% | 278 |
|
|
2015
Q2 | $501K | Buy |
+9,459
| New | +$501K | 0.01% | 388 |
|